Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
Aspen Japan Completes Takeover of Marketing Authorization, Distribution Rights for Lexotan
Aspen Japan said on September 1 that it has completed its takeover of the Japanese marketing authorization and distribution rights for the psychoneurotic agent Lexotan (bromazepam).Chugai Pharmaceutical previously held the marketing authorization for the drug, which was distributed by Eisai.…
To read the full story
Related Article
- Aspen Japan to Take Over Anti-Anxiety Med Lexotan
July 2, 2020
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





